Epistem - Ownership and Business Overview

Life ScienceCompany

Epistem Ownership

Who owns Epistem?

Epistem is owned by Foresight Private Equity. It was acquired on June 12, 2018.

Is Epistem PE-backed?

Yes. Epistem is owned by private equity investor Foresight Private Equity.

Epistem Business Overview

Where is Epistem headquartered?

Epistem is headquartered in Manchester, United Kingdom.

What sector is Epistem in?

Epistem is a life science company.

When was Epistem founded?

Epistem was founded in 2000.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

Epistem

Epistem Ltd.

48 Grafton Street,
Manchester, M13 9XX
United Kingdom,
+44 (0)161 850 7600
www.epistem.co.uk

Epistem is a differentiated life sciences services company that focuses on providing research services for both pre-clinical and clinical development across several specialist therapeutic areas, including oncology and inflammatory diseases. Clients include several global pharmaceutical businesses, US Biodefense programs, and niche biotechnology companies. Epistem was founded in 2000 and is based in Manchester, United Kingdom.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.